SCHWARZENBRUCK, GERMANY, June 26, 2017 – IBA (Ion Beam Applications S.A.), the global high-tech leader in the next generation of proton therapy solutions and radiation therapy integrated quality assurance for the treatment of cancer, announces the accreditation of an ICC training course by the European Board for Accreditation in Medical Physics (EBAMP). IBA Dosimetry successfully passed the evaluation for its ICC training course “Small Fields and FFF: The New Regulation DIN 6809-8 in Theory and Hands-on Practice.” This is the first training for which IBA applied for accreditation under the new procedure set by the European Federation of Medical Physics Associations (EFOMP). The training was judged according to the EBAMP protocol and has been assigned with 23 credit points at EQF Level 7.
Following a new European Accreditation procedure for trainings in Medical Physics, EFOMP has installed the committee EBAMP (www.ebamp.eu). The committee strictly evaluates training courses regarding their content, course material and qualification of the lecturers.
Dr. Lutz Müller, director of the ICC, said: “We are proud of having the first ICC course accredited under the new procedure which confirms the professional standard of our course offerings in terms of program, lecturers and state-of-the-art infrastructure including a clinical linac. I have always seen the ICC as an international platform for exchange between physicists. Since its very beginning, we have had students in all our classes from various European countries. The new accreditation system strengthens the ‘European Spirit’ and adds a great value to our course participants.”
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About International Competence Center (ICC)
IBA Dosimetry believes ongoing education and training are among the most important functions for medical physicists to achieve the highest level of clinical safety and efficiency. In order to invest in the future of its customers, IBA Dosimetry developed the CAREprogram, which supports customers with Enhanced Trainings, Expert Services, and Engaging Events. As an Enhanced Trainings initiative, IBA Dosimetry built the International Competence Center (ICC), one of the most modern and sophisticated training centers in Dosimetry. At the ICC, Radiation Therapy and Medical Imaging Dosimetry healthcare professionals have the opportunity to experience hands-on enhanced training courses, which help them optimize their clinical applications using IBA Dosimetry’s integrated quality assurance technology, as well as other modalities. More information at: www.icc-ibadosimetry.com
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world. IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com.
